Search

1 to 10 of 360
Sort by

Library Entry
Triage and Management of Pyrexia

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses triage and management of pyrexia in patients receiving BRAF/MEK inhibitor therapy. Click here to watch "Triage and Management of Pyrexia" #Melanoma #Video #CollaborativePartner #AdverseEvents ...


Library Entry
Management of Cardiac AEs Associated With BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the management of cardiac AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Management of Cardiac AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma #Video #CollaborativePartner...


Library Entry
Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the steps to recognize and manage ocular AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma ...


Library Entry
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-se

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on patients treated with immune-checkpoint blockade followed by targeted therapy, or vice versa, who experienced cutaneous toxicities with unique histological patterns, a feature that has not been well described in...


Library Entry
Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress Clinical Trials Recording

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Theodore F. Logan, MD, and David F. McDermott, MD,...



Library Entry
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a man with Crohn’s disease actively requiring immunosuppressive therapy who subsequently received pembrolizumab for metastatic melanoma. Authors: Christopher C. Frohne , Ernesto M. Llano , Ashley Perkovic , ...


Library Entry
Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a 68-year-old with metastatic melanoma, who developed transverse myelitis in the setting of immune checkpoint blockade and spinal irradiation for vertebral metastases. Authors: Victoria A. Chang , Daniel R....


Library Entry
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a commentary that provides a narrative summary of their findings in light of the current clinical knowledge relevant to the understanding of immune-related enterocolitis. Author: Khashayar Esfahani JITC(2018) 6:154 #Article ...


Library Entry
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report of a patient with stage IV pulmonary adenocarcinoma treated for 6 months with nivolumab who developed bilateral sterile conjunctivitis followed by oropharyngeal mucositis and esophagitis complicated by a severe...